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Background.T oe v a l u a t ed i ﬀerences between Goldmann Applanation Tonometry (GAT) and Dynamic Controur Tonometry
(DCT) following trabeculectomy. Methods. Thirty eight glaucomatous eyes with a history of trabeculectomy (Trabeculectomy
group, TG), 20 eyes without a history of trabeculectomy but with a history of latanoprost use (Latanoprost group, LG), and 19
nonglaucomatous eyes (Control group, CG) were included. GAT-IOP, DCT-IOP, the diﬀerence between them (dIOP), the central
corneal thickness (CCT), the axial length (AL), and the depth of the anterior chamber (ACD) were measured. Results.d I O Pw a s
signiﬁcantly higher in TG (5.19mmHg) than in LG (4.01mmHg) and CG (1.98mmHg). Correlations between AL and dIOP
were statistically signiﬁcant in both TG and LG but not in CG whereas correlations between dIOP and other clinical parameters
examined were statistically not signiﬁcant in all groups. Conclusions. The signiﬁcantly higher dIOP in TG implies that the bio-
mechanical properties of the ocular walls are altered following trabeculectomy.
1.Introduction
Diﬀerences in the measurements of the intraocular pressure
(IOP) by diﬀerent tonometry methods, such as Goldmann
Applanation Tonometry (GAT) and Dynamic Contour
T o n o m e t r y( D C T ) ,h a v eb e e np r e v i o u s l yd e t e c t e di ng l a u c o -
matouseyesundertreatmentwithlatanoprost andhavebeen
used as indicators of the biomechanical behaviour of the
eye [1, 2]. Perhaps the most important determinator of the
latter is ocular rigidity, corresponding to the mathematical
relationship between pressure and volume changes of the
eye [3, 4]. Ocular rigidity may be altered by conditions
aﬀecting the structural integrity of the ocular walls, such as
traumaorsurgery[5].Inthecaseoftrabeculectomy,apartial
thickness scleral ﬂap (varying in depth or surface area)
is created adjacent to the corneoscleral limbus, potentially
modifying the biomechanical properties of the ocular walls
[5–7]. This study aims at evaluating the diﬀerence between
GAT and DCT (dIOP) in glaucomatous eyes treated with
trabeculectomy, in glaucomatous eyes under topical treat-
ment with latanoprost as well as in a control group of non-
glaucomatous eyes and at correlating results with clinical
information. Findings could help in assessing the potential
eﬀects of trabeculectomy on ocular rigidity and its possible
role in the long-term modiﬁcation of the clinical behaviour
of glaucoma.
2.MaterialsandMethods
This is a prospective nonrandomized cohort study compar-
ing three groups of subjects: a post-trabeculectomy group, a
latanoprost group, and a normal control group. All patients
included were Caucasians, consecutively recruited from the
Department of Ophthalmology of the University Hospital
of Heraklion, in Crete, Greece. Patients with a history
of cataract or refractive surgery, trauma or inﬂammation
in either eye were excluded to avoid potential eﬀects of2 Journal of Ophthalmology
diﬀerent intraocular lens implants (IOLs) or aphakia as
well as diﬀerent wound healing responses on measurements.
The Trabeculectomy Group (TG) included glaucomatous
patients with a history of 1 or 2 trabeculectomies in at
least 1 eye. In all eyes of the TG, the target intraocular
pressure (IOP) had been achieved, without any medication.
The setting of a target IOP had been based on the formula
proposed by Jampel: “Target IOP = Maximum initial IOP
∗(1 − Maximum initial IOP/100) − Z”, where Z is an
optic nerve damage severity factor graded from 0 (for
glaucoma suspects) to 5 (for end-stage glaucoma) [8]. The
Latanoprost Group (LG) included patients with glaucoma
in both eyes in whom target IOP (as previously mentioned)
had also been achieved in at least 1 eye using latanoprost
eye drops (as monotherapy) without a history of previous
ocular surgery. The Control Group (CG) included cataract
surgery candidates in whom glaucoma had been excluded in
both eyes, who had no previous history of ocular surgery
or trauma and who received no ocular medications. In all
TG and LG eyes, target IOP had been reached at least
5 months prior to recruitment. The presence or absence
of glaucoma was separately examined by 2 independent
experienced examiners (ETD and MKT) and only patients
with consent from both examiners were included. Criteria
used for glaucoma diagnosis included IOP measurements
consistently above 21mmHg, a cup-to-disk ratio above 0.5
and in automated perimetry (with central 30-2 threshold
test, Humphrey Field Analyzer/HFA II-I, 30-2, Carl Zeiss-
Meditec Inc., Dublin, Calif, USA), and a Pattern Standard
Deviation (PSD) score outside 95% limits of the normal
reference. In all groups only one eye was enrolled per
patient. In the case of TG patients with an equal number
of trabeculectomies for both eyes, only the right eye was
enrolled otherwise the eye with the greater number of
procedures was enrolled. In the case of LG with latanoprost
monotherapy in one eye and additional topical medications
in the fellow eye, only the eye with latanoprost monotherapy
was enrolled whereas in case of latanoprost monotherapy in
both eyes only the right eye was enrolled. In the case of CG,
only the right eye was enrolled. All patients signed a written
informed consent form in accordance with the tenets of the
Declaration of Helsinki.
All primary trabeculectomies were unenhanced (per-
formed without the use of adjunctive intraoperative
antimetabolites) and all had been performed by the same
surgeon (ETD). The procedure was performed in all cases
under topical anesthesia which included proparacaine eye
drops and the injection of 2ml of ropivacaine subconjuncti-
vally. The latter was used to both anesthetize the area of ﬂap
creation (which in primary cases was always at the 12 o’clock
position of the corneoscleral limbus) and hydro-dissect the
conjunctiva from the underlying Tenon’s capsule. A radial
conjunctival incision was performed in all cases to facilitate
exposure of the scleral bed, followed by an incision along the
corneoscleral limbus to create a fornix-based conjunctival
ﬂap. Wide subconjunctival dissection was then performed
followed by removal of any remaining Tenon’s capsule
overlyingtheareaofscleralﬂap.A4 ×4mmpartialthickness
scleral ﬂap was then marked (using monopolar diathermy)
and created (using a 15
◦ angled blade and a beaver blade)
until the plane of dissection reached clear cornea (anteriorly
to the scleral spur). At this point, a side port was created
and then the anterior chamber was entered with a 15
◦ blade
anteriorly to the scleral spur. Trabeculectomy and iridectomy
were performed (using a 0.75mm corneoscleral punch and
Vannas scissors, resp.), and the scleral ﬂap was closed with
2 nylon sutures (10.0). The patency of trabeculectomy was
tested by injecting balanced salt solution from the side port
and observing the outﬂow from the trabeculectomy site and
at that point adjustment of suture tying was performed as
needed. The conjunctiva was then closed with 2 tight vicryl
sutures (7.0) at the ends of the fornix-based ﬂap forcing
the conjunctiva ﬁrmly against the scleral bed to eﬀectively
seal the wound along the limbus. The remaining radial
incision was also sutured with 7.0 vicryl sutures. In case a
secondary trabeculectomy was performed for failed primary
procedures (for patients who necessitated oral acetazolamide
to control the IOP), the procedure was repeated in the same
way, always nasally to the initial site (at the superior-nasal
conjunctiva) to preserve the superior-temporal quadrant for
possible future antiglaucomatous valve implantation. In all
cases of a secondary trabeculectomy, Mitomycin-C 0.2% was
also used (applied episclerally for 2min).
GAT-IOP (mmHg), DCT-IOP (mmHg), dIOP, Central
Corneal Thickness (CCT, μm), AL (mm), and the anterior
chamber depth (ACD) were examined in all patients by an
experienced examiner (EG) who was masked against group
classiﬁcation. The latter had been performed previously
a n dh a db e e nb a s e do ne x a m i n a t i o n se v a l u a t e db yo t h e r
examiners (ETD and MKT). The number or previous
trabeculectomies in the TG (1 or 2) and the postoperative
interval following the last trabeculectomy (in months) were
also recorded. In the case of TG and LG, the peri-papillary
nerve ﬁber thickness was also measured with GDx-VCC
(Carl Zeiss Meditec, Dublin, Calif, USA) and the universal
Nerve Fiber Index (NFI) was recorded. In the case of DCT
(SMT Swiss Microtechnology AG, Port, Switzerland), the
mean value of 3 readings of good quality, that is, Q1-
Q3, as recommended by the manufacturer, was recorded.
GAT was performed at least 10 minutes after DCT. The
diﬀerencebetween GAT-IOP and DCT-IOP (dIOP) wasthen
calculated. CCT, ACD, and AL were examined with the
Alcon OcuScan RxP Ophthalmic Ultrasound System (Alcon
laboratories, Alcon, Irvine, Calif, USA). A 20Mhz probe
was used for pachymetry (with a resolution of ±1μma n d
an accuracy of ±5μm) and a 10Mhz probe was used for
biometry (with a resolution of ±0.1mm and a theoretical
accuracy of ±0.05mm). Ten successive measurements for
AL, CCT, and ACD were taken in all cases and the mean
was recorded. All clinical ophthalmic examinations were
performed by the same experienced examiner (EG) who was
masked against the classiﬁcation of participants into TG, LG,
and CG.
The TG included 38 eyes of 38 patients (21 males,
55.26%), aged 71.19 ± 5.70 (55–84) years (mean ± SD,
range). The LG included 20 eyes of 20 patients (11 males,
55.00%), aged 71.38 ± 4.37 (48–80) years. The CG included
19 eyes of 19 patients (10 males, 57.89%), aged 70.31 ± 7.16Journal of Ophthalmology 3
Table 1: Mean NFI, AL, CCT, ACD, GAT-IOP, DCT-IOP, and dIOP
scores in TG, LG, and CG as well as ANOVA F values and respective
levels of statistical signiﬁcance.
Parameter TG LG CG F P
NFI 42.14 39.28 16.89 2.08 .37
AL (mm) 23.18 22.95 23.01 2.34 .11
CCT (μm) 513.26 510.31 527.84 4.28 .04
ACD (mm) 2.74 2.92 3.03 2.98 .09
GAT-IOP (mmHg) 14.54 15.75 15.11 0.38 .68
DCT-IOP (mmHg) 19.73 19.76 17.09 1.44 .24
dIOP (mmHg) 5.19 4.01 1.98 7.07 .01
(51–79). In the case of TG, 26 eyes had been operated once
(68.42%)and12eyeshadbeenoperatedtwice(31.57%).The
mean interval following the last procedure in the TG was
17.56 ± 2.38 (5–36) months.
Statistical analysis of ﬁndings was performed using SPSS
8.0 (SPSS, Chicago, IL, USA). Statistical signiﬁcance was
set at 0.05. Diﬀe r e n c e si nG A T ,D C T ,d I O P ,C C T ,A L ,
ACD, and age between groups were examined using one-
way Analysis of Variance (ANOVA) whereas diﬀerences in
gender distribution were examined with Pearson’s chi square
test. Post-hoc analysis of diﬀerences between groups was
performed with Dunnett’s T3 test. The correlations between
GAT, DCT, or dIOP and CCT, AL, ACD or patients’age were
examined in all groups using Pearson’s bivariate correlation
coeﬃcient. In the TG, correlations between dIOP and the
postoperative interval were also examined using Pearson’s
bivariate correlation coeﬃcient whereas diﬀerences in GAT,
DCT, and dIOP between patients having undergone 1 or 2
procedures were examined using independent samples t-test.
3. Results
Diﬀerences in GAT-IOP, DCT-IOP, age, AL, and ACD
between groups were statistically not signiﬁcant (one-way
ANOVA). Diﬀerences in gender distribution between groups
were also statistically not signiﬁcant (Pearson’s Chi square
test). CCT was signiﬁcantly lower in both TG and LG,
compared with CG (Dunnett’s T3 test P = .02) whereas
diﬀerences in CCT between TG and LG were statistically
not signiﬁcant. The dIOP was signiﬁcantly higher in TG,
compared with both CG and LG as well as in LG, compared
with CG (one-way ANOVA, Dunnett’s T3 test). AL, CCT,
ACD, GAT-IOP, DCT-IOP, and dIOP values in all groups as
well as ANOVA F values and respective levels of statistical
signiﬁcance are presented in Table 1.
Among TG patients, dIOP was also signiﬁcantly higher
in patients with a history of 2 procedures, compared with
patients with a history of 1 procedure (independent samples
t-test value 2.46, P = .03). On the contrary, the correlation of
dIOP with the postoperative interval from the last procedure
was statistically not signiﬁcant (Pearson’s bivariate correla-
tion coeﬃcient). Correlations between dIOP and patients’
age, CCT, or ACD were statistically not signiﬁcant in all
groups (Pearson’s bivariate correlation coeﬃcient). On the
contrary,correlationsbetweenALanddIOPwerestatistically
signiﬁcant in both TG (Pearson’s bivariate correlation coeﬃ-
cient 0.31, P = .01) and LG (Pearson’s bivariate correlation
coeﬃcient 0.26, P = .03) but not in CG. Scattergrams of
the correlations between dIOP and AL in the TG, LG, and
CG with respective trend lines, correlation coeﬃcient values
and p-values are presented in Figures 1(a), 1(b),a n d1(c),
respectively.
4. Discussion
This study examined dIOP in glaucomatous eyes in which
target IOP had been reached following 1 or 2 trabeculec-
tomies (without any medical treatment), in glaucomatous
eyes also successfully treated with latanoprost as monother-
apy, as well as in a control group of non-glaucomatous eyes.
Results imply that dIOP is signiﬁcantly increased follow-
ing trabeculectomy which could be related with induced
alterations to the biomechanical properties of the ocular
walls.
DCT measurements are produced by a sensortip requir-
ing no applanation of the corneal surface, so they are theo-
retically not aﬀected by any force-to-pressure translations, as
opposed to GAT [9, 10]. Thus DCT measurements may be
less dependent on corneal biomechanical factors (especially
corneal thickness) than GAT [11], which is also potentially
aﬀected by a massaging eﬀect on the aqueous associated with
applanation [1]. A previous study has reported increased
dIOP values in glaucomatous eyes under monotherapy
with latanoprost, compared with glaucomatous eyes under
medical treatment with no prostaglandin analogues (PGA)
and has concluded that the increase in dIOP may reﬂect
connective tissue remodelling (possibly due to the induction
of metalloproteinases by latanoprost) in the ocular walls
and thus alterations in their biomechanical properties [1].
Findings from the present study imply that trabeculectomy
may also create measurable long-lasting changes in ocular
bio-mechanics. Previous studies have stressed the potential
eﬀects of the creation of partial thickness ﬂaps on the
tectonic properties of ocular walls [5, 6]. In the case of
Laser in Situ Keratomileusis (LASIK), the corneal ﬂap is
never fully reintegrated into the remaining corneal tissue
so it does not participate in its tectonic structure [12, 13].
Furthermore, profound changes in corneal bio-mechanics
have been described following LASIK [14]. Undoubtedly,
scleralﬂapcreationintrabeculectomydiﬀersinmanyaspects
from corneal ﬂap creation in LASIK, including diﬀerences
in size and depth, suturing and covering with conjunctiva
as well as the posttrabeculectomy sharp decreased in IOP.
On the other hand, both cornea and sclera are relatively
avascular tissues, implying that long-term adhesion of the
partial thickness ﬂaps on their underlying beds may be
incomplete. The fact that both corneal ﬂap (in LASIK) and
partial thickness scleral ﬂap (in trabeculectomy) can be re-
raised in cases of revision of the initial procedure further
supports this concept [12–15].
In all eyes that necessitated a second trabeculectomy in
this study a new ﬂap was created, nasally to the initial ﬂap,4 Journal of Ophthalmology
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Figure 1: Scattergrams of the correlations between dIOP and AL in the TG (a), LG (b), and CG (c) with respective trend lines, correlation
coeﬃcient values and P-values.
instead of revising the site of the initial procedure. This
strategy was chosen in an eﬀort to reduce any toxic eﬀects on
the sclera at the initial trabeculectomy site, since Mitomycin-
C was applied in all secondary procedures, according to
previously proposed protocols [16] .T h ef a c tt h a te y e sw i t h
a history of 2 trabeculectomies displayed higher dIOP,
compared with eyes with a history of 1 trabeculectomy,
supports the possibility that the added eﬀect of 2 partial
thickness scleral ﬂaps may augment any induced alterations
in ocular biomechanics. On the other hand, this may also
reﬂect wound healing modiﬁcation by Mitomycin-C, which
was only used in secondary procedures in the present study.
Interestingly, dIOP in this study was not correlated with the
postoperativeintervalfollowingthelasttrabeculectomy.This
ﬁnding implies that any changes in the elastic behaviour of
theocularwallsfollowingtrabeculectomyarenotcontinuous
but instead are completed at some point (possibly early)
along the postoperative course.
In this study, all eyes of the TG group had in the past
been treated with PGA before the ﬁrst trabeculectomy. PGA
u s eh a da l s ob e e nr e p e a t e df o rs o m et i m ei nm o s te y e sw i t h
failed trabeculectomies before the decision to proceed to a
secondary procedure. Taking into account that latanoprost
has been found to signiﬁcantly increase dIOP [2], the
increased dIOP levels in eyes of the TG may, at least in part,
also reﬂect previous PGA use. However, the fact that dIOP
was signiﬁcantly higher in TG compared with LG implies
that trabeculectomy may exert added eﬀects on dIOP levels.
The duration of latanoprost use has not been signiﬁcantly
associated with dIOP by a previous study [2]. Therefore,
any potential diﬀerences in the duration of latanoprost use
between TG and LG possibly have not aﬀected the recorded
diﬀerence in dIOP between the 2 groups.
The fact that AL was signiﬁcantly correlated with dIOP
in both TG and LG may also reﬂect previous use of PGA
in both groups, taking into account that AL (and not
CCT) has been previously correlated with latanoprost use
[2]. As previously mentioned, this ﬁnding may possibly be
attributed to remodelling of the scleral collagen or changes
in choroidal circulation associated with latanoprost, such as
an increase in ciliary body thickness or changes in choroidal
vascular permeability [17, 18]. The correlation of AL with
dIOP reﬂects the contribution of both anterior and posterior
ocular walls to the total ocular biomechanical behaviour (as
opposed to CCT which reﬂects only its corneal component).
Therefore, the fact that the correlation of AL with dIOP was
more pronounced for TG, compared with LG, implies that
trabeculectomy may aﬀect total ocular rigidity.
The nonrandomized design and the relatively small
number of participants may be considered as weak points
for this study. Furthermore, the fact that the postoperative
interval on which patients were examined was not stable
but instead varied (5–36 months) should be taken into
consideration. The prospective consecutive recruitment and
fact that all measurements were performed by the same
experienced examiner who was masked against patients’
classiﬁcation possibly enhance the validity of results. The
dIOP score in the present study was comparable to that
reported in previous studies [10, 11] whereas TG, LG, and
CG did not diﬀer in patients’ age (which has been found
to aﬀect dIOP by previous studies [1]). The fact that CCT
was signiﬁcantly lower in both TG and LG (glaucomatous
eyes), compared with CG (non-glaucomatous eyes) may be
attributed to the inverse correlation between CCT and the
predisposition for glaucoma [19]. However, dIOP may be
morepronouncedonlyinverythickorverythincorneas[20]
(which was not the case for patients in this study) whereas
the reported eﬀect of CCT on GAT is statistically weak (R2
ranging from 0.06 to 0.17) [21]. Therefore, we believe that
thediﬀerenceinCCTbetweengroupsinthisstudyisunlikely
to have aﬀected results.
Therearecontroversialreportsontheeﬀectsofglaucoma
on ocular rigidity [22–24]a sw e l la st h ed i ﬀerences in dIOP
between treated and untreated glaucomatous eyes [1]. In the
present study, the facts that target IOP had been reached in
both TG and LG and that NFI did not diﬀer signiﬁcantly
between them imply that glaucoma was equally advanced
in both groups. Therefore, the observed diﬀerences in dIOP
between LG and TG are possibly related with trabeculectomy
rather than with the glaucomatous process per se.Journal of Ophthalmology 5
Recent evidence suggests that the biomechanics of the
corneoscleral shell aﬀect cellular deformation in the optic
nervehead,asrelativelythick,solidscleraismuchstiﬀerthan
both neural tissue and the porous lamina cribrosa [25]. Scle-
ral deformation depends on IOP and—more interestingly—
on the mechanical properties of the sclera [25]. Findings
from this study imply that apart from lowering the IOP
trabeculectomy might have additional eﬀects related with
changes in scleral biomechanics. Larger randomized studies
would be required to further explore this possibility. Results
could help in better understanding the pathophysiology
underlying ocular rigidity as well as in the design of more
powerful procedures for the management of glaucoma.
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